With reference to the Board meeting notice dated July 30 2019 we hereby inform that the Board of Directors in its meeting held on August 08 2019 has inter-alia transacted the following business:
Approval of the Unaudited Financial Results of the Company (Standalone & Consolidated) for the quarter ended June 30 2019.
In view of the aforesaid we hereby enclose the Unaudited Financial Results (Standalone & Consolidated) for the quarter ended June 30 2019 along with the Limited Review report issued by B S R & Co. LLP Statutory Auditors of the Company.
The aforesaid financial results along with Limited review report are also being uploaded on the website of the Company i.e. www.advancedenzymes.com
This is for your information and for public at large.